Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy

Antonello D'Andrea1, Pio Caso, Sergio Severino

  • 1Department of Cardiology, Second University of Naples, Monaldi Hospital, Via G. Martucci 35, 80121 Naples, Italy. adandrea@napoli.com

European Heart Journal
|December 21, 2005
PubMed

Insights

Doppler myocardial imaging (DMI) can predict cardiac events in hypertrophic cardiomyopathy (HCM). Intraventricular delays (intra-V-Del) greater than 45 ms identify HCM patients at high risk for sudden cardiac death.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by non-uniform left ventricular (LV) hypertrophy, leading to heterogeneous regional LV systolic function.
  • Assessing myocardial activation delay is crucial for predicting cardiac events in HCM patients.

Purpose of the Study:

  • To evaluate Doppler myocardial imaging (DMI) indexes of myocardial activation delay as predictors of cardiac events in patients with HCM.
  • To identify specific DMI parameters that correlate with increased risk of sudden cardiac death in HCM.

Main Methods:

  • The study included 123 HCM patients and 123 age- and sex-matched controls.
  • Pulsed DMI was used to assess myocardial peak velocities, systolic time-intervals, and intraventricular (intra-V-Del) and interventricular (inter-V-Del) systolic delays in basal myocardial segments.
  • Patients were followed up for an average of 48.4 months.

Main Results:

  • HCM patients exhibited lower systolic and early-diastolic peak velocities and significant inter- and intra-V delays compared to controls.
  • During follow-up, 16 cardiac deaths (12 sudden deaths) occurred in HCM patients.
  • DMI intra-V-Del was the strongest independent predictor of sudden cardiac death (P<0.0001). An intra-V-Del > 45 ms demonstrated 88.8% accuracy in identifying patients at high risk for ventricular tachycardia and sudden cardiac death.

Conclusions:

  • DMI indexes, particularly intra-V-Del, offer valuable information for risk stratification in HCM patients.
  • These findings can aid in identifying HCM subgroups at increased risk for ventricular arrhythmias and sudden cardiac death.
  • Early identification allows for more intensive treatment and monitoring of high-risk individuals.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...